Advances in Lung Cancer 01 , 1-4 /HO J. Treatment of non-small cell lung cancer in the era of targe-ted therapy [J]. Advances Lung Cancer, 2011,1 :1 -4.Treatment of non-small cell lung cancer in the era of targeted therapy. HO J. Advances Lung Cancer . 2011...
Lung cancer Small cell Non small cell Mesothelioma Treatment Surgery Chemotherapy Radiotherapy EORTC Trials 1.. Non-small cell lung cancer Many things have changed in the history of non-small cell lung cancer (NSCLC) over the past 50 years. Much of it has been summarized in the special issue...
imaging treatment in non-small cell lung cancer session id: s2-cch04 refresher course ama pra category 1 credit™: 1.00 arrt category a+ credits (in-person attendees only): 1.00 location e351 (opens in a new tab) speaker(s):jane p. ko, md; mylene thi mytien truong, md...
SUMMARYOver the last fifteen years, significant advances have been made in understanding the mechanisms and pathways that drive tumor growth in patients with non-small cell lung cancer (NSCLC). Molecular testing has become routine, and results directly impact clinical decision-making. The discovery ...
Stage IV non–small-cell lung cancer (NSCLC) patients with oligometastases (< 5 metastatic lesions) may experience long-term survival when all macroscopic tumor sites are treated radically, but no prospective data on NSCLCs with synchronous oligometastases are available. Methods A prospective single...
Summary: Between January 1, 1991 until December 31, 1996, 286 patients with non-small cell lung cancer were diagnosed and treated in the Department of Tuberculosis and Respiratory Diseases and Palliative Care Unit in Babice nad Svitavou, Czech Republic. There were 251 (87.8 %) males and 35 (...
过去的二十年间,肺叶切除及系统性淋巴结清扫已成为早期非小细胞肺癌(non-small cell lung cancer,NSCLC)的标准手术方式[1]。然而,由于肺癌筛查工作的广泛深入,肺部结节数量显著增加,尤其是直径2 cm以内的早期肺癌所占比例正在逐步提高。在这种情况下,是否仍需对这...
1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 2Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Ca...
Non-small-cell lung cancer is the most common type of lung cancer. It's serious, but treatment can sometimes cure it or stop it from getting worse. WebMD explains.
The safety of afatinib for the treatment of non- small cell lung cancer[J]. Expert Opin DrugSaf, 2016, 15(11):1563-1572.The safety of afatinib for the treatment of nonsmall cell lung cancer. Barron F,de la Torre-Vallejo M,Luna-Palencia RL,et al. Expert Opin Drug Saf . 2016...